• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三环类抗抑郁药难治性抑郁症中的锂盐。脑5-羟色胺功能增强与临床疗效的相关性。

Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.

作者信息

Cowen P J, McCance S L, Ware C J, Cohen P R, Chalmers J S, Julier D L

机构信息

Psychopharmacology Research Unit, Littlemore Hospital, Oxford.

出版信息

Br J Psychiatry. 1991 Sep;159:341-6. doi: 10.1192/bjp.159.3.341.

DOI:10.1192/bjp.159.3.341
PMID:1659918
Abstract

The addition of lithium to the tricyclic antidepressant medication of 23 patients with major depression resulted in an increase in the prolactin response to intravenous L-tryptophan after both four days and four weeks of treatment. The extent of this increase did not distinguish the ten patients who were classified as clinical responders (greater than 50% reduction in score on the HRSD). Among the responders there was a modestly significant correlation between the decrease in score on the HRSD and the enhancement of tryptophan-induced prolactin release. Some responders, however, showed very little change in this endocrine response over the four weeks of lithium treatment. Lithium may increase brain 5-HT function in tricyclic-resistant depression but there is only limited support for the hypothesis that changes in brain 5-HT function are involved in the antidepressant effect of this treatment combination.

摘要

在23名重度抑郁症患者的三环类抗抑郁药物治疗中加入锂盐,结果显示,在治疗4天和4周后,静脉注射L-色氨酸所引起的催乳素反应均有所增加。这种增加的程度并不能区分出被归类为临床反应者的10名患者(汉密尔顿抑郁量表评分降低超过50%)。在反应者中,汉密尔顿抑郁量表评分的降低与色氨酸诱导的催乳素释放增强之间存在适度显著的相关性。然而,一些反应者在锂盐治疗的四周内,这种内分泌反应变化很小。锂盐可能会增加对三环类药物耐药的抑郁症患者大脑中的5-羟色胺功能,但关于大脑5-羟色胺功能变化参与这种联合治疗的抗抑郁作用这一假说,仅有有限的支持证据。

相似文献

1
Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.三环类抗抑郁药难治性抑郁症中的锂盐。脑5-羟色胺功能增强与临床疗效的相关性。
Br J Psychiatry. 1991 Sep;159:341-6. doi: 10.1192/bjp.159.3.341.
2
Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.
Psychopharmacology (Berl). 1989;99(2):230-2. doi: 10.1007/BF00442813.
3
Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.在三环类抗抑郁药抵抗的单相抑郁中添加碳酸锂。与三环类抗抑郁药和锂离子对血清素系统的神经生物学作用的相关性。
Arch Gen Psychiatry. 1983 Dec;40(12):1327-34. doi: 10.1001/archpsyc.1983.01790110069012.
4
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
Arch Gen Psychiatry. 1984 Apr;41(4):391-7. doi: 10.1001/archpsyc.1984.01790150081011.
5
[Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].[碳酸锂增效治疗三环类抗抑郁药抵抗性抑郁症]
Harefuah. 1991 Dec 1;121(11):429-30.
6
Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study.
Am J Psychiatry. 1985 Feb;142(2):220-3. doi: 10.1176/ajp.142.2.220.
7
Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
J Clin Psychopharmacol. 1997 Feb;17(1):44-8. doi: 10.1097/00004714-199702000-00008.
8
Lithium augmentation in geriatric depression.
J Affect Disord. 1990 Dec;20(4):217-23. doi: 10.1016/0165-0327(90)90053-b.
9
Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.
Arch Gen Psychiatry. 1989 Jan;46(1):13-9. doi: 10.1001/archpsyc.1989.01810010015002.
10
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.文拉法辛与锂盐单药治疗双相II型重度抑郁发作的短期比较:一项随机开放标签研究。
J Clin Psychopharmacol. 2008 Apr;28(2):171-81. doi: 10.1097/JCP.0b013e318166c4e6.

引用本文的文献

1
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.心境稳定剂治疗可增加双相抑郁患者 5-羟色胺 1A 受体结合。
J Psychopharmacol. 2013 Oct;27(10):894-902. doi: 10.1177/0269881113499204. Epub 2013 Aug 7.
2
[Twenty-five years of lithium augmentation].[锂盐增效治疗的二十五年]
Nervenarzt. 2007 Nov;78(11):1237-47. doi: 10.1007/s00115-007-2273-5.
3
Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.
Drug Saf. 1998 Dec;19(6):455-64. doi: 10.2165/00002018-199819060-00003.